GK

Gopi Krishna Bobbala

Active Director Director DIN 08504096
DIN 08504096 First appointment Jul 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value •••• Premium profile

About Gopi Krishna Bobbala

Data last updated:

Gopi Krishna Bobbala is a Director at Medrhans Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Medrhans Pharmaceuticals Private Limited reported revenue of ₹8.54 Cr (FY 2025).

DIN 08504096
Primary Designation Director
Industry Pharma
First Appointment 08 Jul 2019
Oldest Company Age 7 yrs
Largest company Medrhans Pharmaceuticals Private Limited · ₹8.54 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jul 20192018₹8.54 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Medrhans Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gopi Krishna Bobbala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gopi Krishna Bobbala

Gopi Krishna Bobbala currently holds 1 directorship: Medrhans Pharmaceuticals Private Limited (Director, since 08 Jul 2019, revenue ₹8.54 Cr (FY 2025)).

Gopi Krishna Bobbala was first appointed on 08 Jul 2019 as Director at Medrhans Pharmaceuticals Private Limited.

The current boards of Gopi Krishna Bobbala's companies include Chiranjeevi Gadupudi (Medrhans Pharmaceuticals Private Limited), Vanga Kondalreddy (Medrhans Pharmaceuticals Private Limited), Venkateswarlu Nalajala (Medrhans Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available